Challenging Cases and Diagnostic Dilemmas-Reference-Cited by-同舟云学术

Challenging Cases and Diagnostic Dilemmas

Published:2002-08-01 Issue:15 Volume:20 Page:3347-3349
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Bomanji J.B.¹,Syed R.¹,Brock C.¹,Jankowska P.¹,Dogan A.¹,Costa D.C.¹,Ell P.J.¹,Lee S.M.¹

Affiliation:

1. Institute of Nuclear Medicine and Meyerstein Institute of Oncology, Middlesex Hospital, London, United Kingdom

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2002.20.15.3347

Reference8 articles.

1. Sarcoid reactions in malignant tumours

2. Hoh CK, Glaspy J, Rosen P, et al: Whole-body FDG PET imaging for staging of Hodgkin’s lymphoma and lymphoma. J Nucl Med 38: 343,1997-348,

3. Whole-body positron emission tomography using fluorodeoxyglucose for staging of lymphoma: effectiveness and comparison with computed tomography

4. Romer W, Hanauske AR, Ziegler S, et al: Positron emission tomography in non-Hodgkin’s lymphoma: Assessment of chemotherapy with fluorodeoxyglucose. Blood 91: 4464,1998-4471,

5. 2-(fluorine-18)fluoro-2-deoxy-D-glucose positron emission tomography in the detection and staging of malignant lymphoma

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. References: 1986–2011;FESTSCHRIFT The Institute of Nuclear Medicine 50 Years;2012

2. Behind Fluorodeoxy-Glucose: the Role of Positron Emission Tomography/Computed Tomography for Fluorine-18 Labelled PET-Tracer Imaging;Imaging Decisions MRI;2008-12

3. Lymphoma;PET-CT in Radiotherapy Treatment Planning;2008

4. The contribution of PET/CT to improved patient management;The British Journal of Radiology;2006-01

5. Letters to the Editor;Leukemia & Lymphoma;2006-01